Secondo Position Paper AIFA sui Farmaci...

25
Secondo Position Paper AIFA sui Farmaci Biosimilari

Transcript of Secondo Position Paper AIFA sui Farmaci...

Page 1: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=

Secondo Position Paper AIFA sui

Farmaci Biosimilari

Page 2: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 3: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 4: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 5: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 6: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 7: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 8: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 9: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 10: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 11: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 12: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 13: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 14: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 15: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 16: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 17: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 18: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 19: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 20: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 21: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 22: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 23: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 24: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=
Page 25: Secondo Position Paper AIFA sui Farmaci Biosimilari3`cXaRb]bTb_]acXbcWaXbZb]`\acQb_\_SbZ_cR_[]b^`cX`\\AHFIc4c\`cYaSVa]^a8c, 9>2 >"14*4;97=;>0=